Beta: Sign in
Shares outstandingAs of 2026-06-30 · filed common shares: 1.73B
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.43%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 1.28%
Short ratioDays to cover, as published by FINRA: 2.67
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 38.20%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 43.00%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for ABT

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 56.61%
Operating marginTTM to Jun 26: 15.77%
Net margin: —
EBITDA marginTTM to Jun 26: 23.17%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 10.67%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 5.62%

Growth

Revenue growth (annual YoY): 5.67%
Revenue growth (latest qtr YoY): 13.02%
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: -51.32%
Net income growth (latest qtr YoY): -47.84%
EPS growth (fwd): Sign in
Net income growth (QoQ): -13.83%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: 3.09
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $5.10B
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $32.60B
Debt / equityas of Jun 26: 63.80%
Current ratioas of Jun 26: 1.38
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 0.80
Operating cash flowTTM to Jun 26: $9.90B
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: $7.82B
TTM revenue / diluted shareDiluted, TTM to Jun 26: 26.68

ABT stock Statistics — Abbott Laboratories filings, insiders & smart money · Instaport